You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

lymphocytic leukemia

Showing 5376 - 5400 of 6,274
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Drug/Agent Toxicity by Tissue/Organ, Leukemia Trial in Canada, United States (silymarin)

Completed
  • Drug/Agent Toxicity by Tissue/Organ
  • Leukemia
  • silymarin
  • Miami, Florida
  • +7 more
Dec 17, 2013

Lymphoma, Small Intestine Cancer, Solid Tumor Trial in New York (pegylated liposomal doxorubicin HCl, picoplatin)

Completed
  • Lymphoma
  • +2 more
  • pegylated liposomal doxorubicin hydrochloride
  • picoplatin
  • New York, New York
    Memorial Sloan-Kettering Cancer Center
Jun 17, 2013

Leukemia Trial in Berkeley Heights (oblimersen sodium, gemtuzumab ozogamicin)

Completed
  • Leukemia
  • oblimersen sodium
  • gemtuzumab ozogamicin
  • Berkeley Heights, New Jersey
    Genta Incorporated
Jan 3, 2014

Leukemia Trial in Los Angeles (danusertib, laboratory biomarker analysis, pharmacological study)

Unknown status
  • Leukemia
  • Los Angeles, California
    Jonsson Comprehensive Cancer Center at UCLA
Dec 17, 2013

Lymphoma, Follicular, Lymphoma, Small Lymphocytic Trial in Houston (autologous human tumor-derived HSPPC-96)

Completed
  • Lymphoma, Follicular
  • Lymphoma, Small Lymphocytic
  • autologous human tumor-derived HSPPC-96
  • Houston, Texas
    M.D. Anderson Cancer Center
Sep 6, 2012

Leukemia Trial in Belgium, Netherlands, Switzerland (cyclosporine, etoposide, mitoxantrone HCl)

Unknown status
  • Leukemia
  • Brussels (Bruxelles), Belgium
  • +11 more
Dec 18, 2013

Leukemia Trial in Edinburgh (recombinant interferon alfa, cytarabine, hydroxyurea)

Unknown status
  • Leukemia
  • recombinant interferon alfa
  • +2 more
  • Edinburgh, Scotland, United Kingdom
    Western General Hospital
Dec 18, 2013

Leukemia, Lymphoma Trial in London (biological, drug, radiation)

Completed
  • Leukemia
  • Lymphoma
  • filgrastim
  • +9 more
  • London, England, United Kingdom
    Medical Research Council Clinical Trials Unit
Dec 18, 2013

Leukemia Trial (IPI-145, Follow-up Visit/Call)

Withdrawn
  • Leukemia
  • (no location specified)
Jan 3, 2014

Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Chronic Myeloid Leukemia Trial in Memphis (Plerixafor)

Completed
  • Acute Lymphoblastic Leukemia
  • +4 more
  • Memphis, Tennessee
    St. Jude Children's Research Hospital
Dec 31, 2013

Chronic Lymphocytic Leukemia Trial in Worldwide (Chlorambucil, R-etodolac + chlorambucil)

Terminated
  • Chronic Lymphocytic Leukemia
  • Caen, France
  • +21 more
Jun 8, 2012

Acute Myelogenous Leukemia, Acute Lymphoblastic Leukemia, Myelodysplastic Syndrome Trial in United States (MLN4924, Azacitidine)

Completed
  • Acute Myelogenous Leukemia
  • +2 more
  • Stanford, California
  • +5 more
Dec 3, 2013

Leukemia Trial in Los Angeles (lintuzumab)

Unknown status
  • Leukemia
  • lintuzumab
  • Los Angeles, California
    Jonsson Comprehensive Cancer Center, UCLA
Dec 18, 2013

Leukemia Trial in United States (PT-523 for Injection)

Withdrawn
  • Leukemia
  • PT-523 for Injection
  • Los Angeles, California
  • +5 more
Dec 2, 2013

Accelerated Phase Chronic Myelogenous Leukemia, Adult Acute Lymphoblastic Leukemia in Remission, Adult Acute Myeloid Leukemia in

Withdrawn
  • Accelerated Phase Chronic Myelogenous Leukemia
  • +102 more
  • management of therapy complications
  • musculoskeletal complications management/prevention
  • (no location specified)
Jul 5, 2012

Acute Leukemia Trial in Seoul (Irinotecan)

Unknown status
  • Acute Leukemia
  • Seoul, Chongno-gu, Korea, Republic of
    Seoul National University Hospital
Nov 17, 2013

Leukemia Trial in Worldwide (biological, drug, procedure, radiation)

Unknown status
  • Leukemia
  • filgrastim
  • +10 more
  • Brno, Czech Republic
  • +187 more
Dec 17, 2013

MDS Trial in Tampa (Dasatinib)

Completed
Has Results
  • Myelodysplastic Syndromes
  • Tampa, Florida
    H. Lee Moffitt Cancer Center and Research Institute
Nov 21, 2013

Myeloproliferative Disorders, Leukemia, Lymphoma Trial (aprepitant, ondansetron HCl)

Withdrawn
  • Myeloproliferative Disorders
  • +7 more
  • (no location specified)
Mar 29, 2013

Leukemia Trial in Baltimore (autologous tumor cell vaccine, rituximab, cyclophosphamide)

Withdrawn
  • Leukemia
  • autologous tumor cell vaccine
  • +2 more
  • Baltimore, Maryland
    Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
May 1, 2012

Acute Lymphoblastic Leukemia Trial in Los Angeles (Daunorubicin, Vincristine, Prednisone, Methotrexate, PEG-Asparaginase,

Completed
  • Acute Lymphoblastic Leukemia
  • Daunorubicin, Vincristine, Prednisone, Methotrexate, PEG-Asparaginase, 6-Mercaptopurine, Cytoxan, Cytosine Arabinoside, VM-26 and 6-Thioguanine
  • Los Angeles, California
    USC/Norris Comprehensive Cancer Center and Hospital
May 20, 2014

Leukemia Trial in Worldwide (lintuzumab, cytarabine, etoposide)

Unknown status
  • Leukemia
  • lintuzumab
  • +3 more
  • Los Angeles, California
  • +58 more
Nov 5, 2013

Breast Cancer, Endometrial Cancer, Kidney Cancer Trial in London (metformin HCl, temsirolimus)

Completed
  • Breast Cancer
  • +5 more
  • London, Ontario, Canada
    London Regional Cancer Program at London Health Sciences Centre
May 29, 2013

Chronic Myeloproliferative Disorders, Infection, Leukemia Trial (Edetate Calcium Disodium, Ethanol,

Withdrawn
  • Chronic Myeloproliferative Disorders
  • +8 more
  • Edetate Calcium Disodium
  • +3 more
  • (no location specified)
Feb 13, 2013

Leukemia, Neutropenia Trial in Cardiff (biological, drug, procedure, radiation)

Unknown status
  • Leukemia
  • Neutropenia
  • filgrastim
  • +13 more
  • Cardiff, Wales, United Kingdom
    University of Wales College of Medicine
Dec 18, 2013